Double trouble I wouldn't hold my breath on zenabis at these levels, pick up opportunities will present themselves around 5cents or lower.
there are many speculative cos currently which have the same potential upside or more at this time and zenabis isn't clearly that cheap considering the dilution, huge debt servicing costs, questionable insiders and looming lawsuits.
At this moment I would say cos like auxly, Alefia health, medmen are safe secure with an upside of over 100%